WCN24-101 KLF2 AGONISTS AS A NOVEL THERAPY FOR DIABETIC DISEASE

Saved in:
Bibliographic Details
Main Authors: fang zhong, John He
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924005369
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850127672576835584
author fang zhong
John He
author_facet fang zhong
John He
author_sort fang zhong
collection DOAJ
format Article
id doaj-art-4b923b5a6d8f4a4db4b3d367bfc1e703
institution OA Journals
issn 2468-0249
language English
publishDate 2024-04-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj-art-4b923b5a6d8f4a4db4b3d367bfc1e7032025-08-20T02:33:36ZengElsevierKidney International Reports2468-02492024-04-0194S22010.1016/j.ekir.2024.02.447WCN24-101 KLF2 AGONISTS AS A NOVEL THERAPY FOR DIABETIC DISEASEfang zhong0John He1new york, Nephrology, United StatesRenal, icahn school of medicine at mount sinai, New Yorkhttp://www.sciencedirect.com/science/article/pii/S2468024924005369
spellingShingle fang zhong
John He
WCN24-101 KLF2 AGONISTS AS A NOVEL THERAPY FOR DIABETIC DISEASE
Kidney International Reports
title WCN24-101 KLF2 AGONISTS AS A NOVEL THERAPY FOR DIABETIC DISEASE
title_full WCN24-101 KLF2 AGONISTS AS A NOVEL THERAPY FOR DIABETIC DISEASE
title_fullStr WCN24-101 KLF2 AGONISTS AS A NOVEL THERAPY FOR DIABETIC DISEASE
title_full_unstemmed WCN24-101 KLF2 AGONISTS AS A NOVEL THERAPY FOR DIABETIC DISEASE
title_short WCN24-101 KLF2 AGONISTS AS A NOVEL THERAPY FOR DIABETIC DISEASE
title_sort wcn24 101 klf2 agonists as a novel therapy for diabetic disease
url http://www.sciencedirect.com/science/article/pii/S2468024924005369
work_keys_str_mv AT fangzhong wcn24101klf2agonistsasanoveltherapyfordiabeticdisease
AT johnhe wcn24101klf2agonistsasanoveltherapyfordiabeticdisease